Who is sponsoring NCT04024722?

NCT04024722 is sponsored by Barzilai Medical Center.

What drugs are being tested in NCT04024722?

Interventions in NCT04024722: In Vitro Fertilization.

What condition does NCT04024722 study?

NCT04024722 studies Poor Ovarian Response, Ovarian Insufficiency.

Is NCT04024722 still recruiting?

NCT04024722 is currently status unknown. Last updated 28 July 2021.

Last reviewed 2021-07-28 · How we verify

NCT04024722

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving in Vitro Fertilization in Women With Poor Ovarian Response

Status unknown NA Last updated 28 July 2021

What this trial tests

NA trial testing In Vitro Fertilization in Poor Ovarian Response in 40 participants. Status unknown.

Timeline

14 January 2020

Primary endpoint
31 July 2021

31 July 2022

Quick facts

Lead sponsor	Barzilai Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	14 January 2020
Primary completion	31 July 2021
Estimated completion	31 July 2022
Sites	1 location across Israel

Drugs / interventions tested

In Vitro Fertilization — full drug profile →

Conditions studied

Poor Ovarian Response — all drugs for Poor Ovarian Response →
Ovarian Insufficiency — all drugs for Ovarian Insufficiency →

Sponsor

Barzilai Medical Center

Who can join

Adults 18 to 45, female only, with Poor Ovarian Response or Ovarian Insufficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Improving the results of in vitro fertilization in women with poor ovarian response and early ovarian insufficiency

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency.
Grin L, Berkovitz-Shperling R, Goldstein G, Michailov Y, et al · · 2025 · cited 1× · PMID 40315958 · DOI 10.1016/j.xfss.2025.04.002

Verify or expand the search:

Other recruiting trials for Poor Ovarian Response

Currently open trials in the same condition.

NCT06645379 — Application of Platelet-rich Plasma (PRP) in Reproductive Medicine · NA · recruiting

Other Barzilai Medical Center trials

Trials by the same sponsor.

NCT06889467 — Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer · recruiting
NCT06773676 — Evaluating the Effectiveness of Using a Home Laser Device to Treat Patients With Knee Osteoarthritis · NA · recruiting
NCT07377461 — Flexible and Navigable Suction Ureteral Access Sheath (FANS) vs Conventional Access Sheaths in RIRS: A Prospective Rando · NA · completed
NCT04975373 — Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions · NA · unknown
NCT03840187 — Correlation Between Colposcopist Findings and Digital Cervicography Employing Gynescope System · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04024722 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Barzilai Medical Center
Last refreshed: 28 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04024722.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing